About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
119 genotypes with 132 annotations displayed of selected term and subterms
Searched Term: decreased organ/body region tumor incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
2610035D17Rikem1Zhgn/2610035D17Rikem1Zhgn
Krasem1Gpt/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6JGpt * CBA) 		decreased gland tumor incidence J:339253
2610035D17Rikem2Zhgn/2610035D17Rikem2Zhgn
Krasem1Gpt/Kras+
Tg(Pdx1-cre)89.1Dam/0
Trp53em3Gpt/Trp53+
(involves: C57BL/6JGpt * CBA) 		decreased gland tumor incidence J:339253
ApcMin/Apc+
(involves: C57BL/6J) 		decreased intestinal adenoma incidence J:268691
ApcMin/Apc+
((AKR/J x C57BL/6J-ApcMin)F1) 		decreased intestinal adenoma incidence J:1879
ApcMin/Apc+
((MA/MyJ x C57BL/6J-ApcMin)F1) 		decreased intestinal adenoma incidence J:1879
ApcMin/Apc+
Arhgef4tm1Taki/Arhgef4+
(B6J.Cg-Arhgef4tm1Taki ApcMin) 		decreased intestinal adenoma incidence J:157023
ApcMin/Apc+
Arhgef4tm1Taki/Arhgef4tm1Taki
(B6J.Cg-Arhgef4tm1Taki ApcMin) 		decreased intestinal adenoma incidence J:157023
ApcMin/Apc+
Arhgef4tm1Taki/Arhgef4tm1Taki
Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Arhgef4tm1Taki Spata13tm1Taki ApcMin) 		decreased intestinal adenoma incidence J:157023
ApcMin/Apc+
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased intestinal adenoma incidence J:135025
ApcMin/Apc+
Cd44tm1Mak/Cd44tm1Mak
(involves: C57BL/6J) 		decreased intestinal adenoma incidence J:204874
ApcMin/Apc+
Cd44tm2Stpa/Cd44tm2Stpa
(involves: C57BL/6J) 		decreased intestinal adenoma incidence J:204874
ApcMin/Apc+
Del(15Rr357-Rr303293)2Jta/Del(15Rr357-Rr303293)2Jta
(involves: C57BL/6) 		decreased colon tumor incidence J:257088
ApcMin/Apc+
Elp3tm1.1Tac/Elp3tm1.1Tac
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL) 		decreased intestinal adenoma incidence J:227334
ApcMin/Apc+
Gt(ROSA)26Sor/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sor ApcMin) 		decreased alimentary system tumor incidence J:66060
decreased mammary gland tumor incidence J:66060
ApcMin/Apc+
Il22tm1Flv/Il22tm1Flv
(involves: 129/Sv * C57BL/6 * C57BL/6J) 		decreased alimentary system tumor incidence J:189217
ApcMin/Apc+
Mmom1C57BL/6J/Mmom1FVB/NTac
(involves: C57BL/6J * FVB/NTac) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Mmom1C57BL/6J/Mmom1FVB/NTac
Mmom3C57BL/6J/Mmom3FVB/NTac
(involves: C57BL/6J * FVB/NTac) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Mmom2129X1/SvJ/Mmom2C57BL/6J
(involves: 129X1/SvJ * C57BL/6J) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
(involves: C57BL/6J * FVB/NTac) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Mmom3C57BL/6J/Mmom3FVB/NTac
(involves: C57BL/6J * FVB/NTac) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Mmom2C57BL/6J/Mmom2FVB/NTac
Mmom4C57BL/6J/Mmom4FVB/NTac
(involves: C57BL/6J * FVB/NTac) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Mmom4C57BL/6J/Mmom4FVB/NTac
(involves: C57BL/6J * FVB/NTac) 		decreased mammary gland tumor incidence J:128481
ApcMin/Apc+
Pla2g2aMom1-r/Pla2g2a+
(either: (AKR/J x C57BL/6J-ApcMin)F1 or (MA/MyJ x C57BL/6J-ApcMin)F1 or (CAST/EiJ x C57BL/6J-ApcMin)F1) 		decreased alimentary system tumor incidence J:15703
decreased intestinal adenoma incidence J:15703
ApcMin/Apc+
Spata13tm1Taki/Spata13+
(B6J.Cg-Spata13tm1Taki ApcMin) 		decreased intestinal adenoma incidence J:157023
ApcMin/Apc+
Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Spata13tm1Taki ApcMin) 		decreased intestinal adenoma incidence J:157023
ApcMin/Apc+
Tg(Vil1-PPARGC1A)#Amos/0
(involves: C57BL/6J * FVB/N) 		decreased alimentary system tumor incidence J:171361
ApcMin/Apc+
Tmem9tm1d(EUCOMM)Wtsi/Tmem9+
(involves: C57BL/6J * C57BL/6N) 		decreased intestinal adenoma incidence J:268691
ApcMin/Apc+
Tmem9tm1d(EUCOMM)Wtsi/Tmem9tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		decreased intestinal adenoma incidence J:268691
ApcMin/Apc+
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J) 		decreased alimentary system tumor incidence J:241611
ApcMin/Apc+
Trp53tm2.1Tyj/Trp53tm2.1Tyj
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2) 		decreased alimentary system tumor incidence J:291671
ApcMin/Apc+
Zfp280cem1Xss/Zfp280cem1Xss
(C57BL/6J-ApcMin Zfp280cem1Xss) 		decreased alimentary system tumor incidence J:331404
Apctm1Tno/Apc+
Rac3tm1.1Bea/Rac3tm1.1Bea
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2) 		decreased alimentary system tumor incidence J:306088
decreased intestinal adenoma incidence J:306088
Apctm2.1Cip/Apc+
Atg7tm1Tchi/Atg7tm1Tchi
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2) 		decreased intestinal adenoma incidence J:227287
Bag1tm1Msd/Bag1+
Tg(SFTPC-RAF1-BxB)1Urr/0
(involves: C57BL/6) 		decreased lung tumor incidence J:95491
Bmi1tm1.1Lees/Bmi1tm1.1Lees
Apctm2Cip/Apc+
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2) 		decreased alimentary system tumor incidence J:204354
decreased colon tumor incidence J:204354
decreased intestinal adenoma incidence J:204354
Bmi1tm1Brn/Bmi1tm1Brn
Apctm2Cip/Apc+
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased alimentary system tumor incidence J:204354
decreased colon tumor incidence J:204354
decreased intestinal adenoma incidence J:204354
Brca1tm1Brn/Brca1tm1.1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		decreased mammary gland tumor incidence J:178595
decreased skin tumor incidence J:178595
Catb/Catb
(C3.Cg-Catb/Anl) 		decreased mammary gland tumor incidence J:5971
Ccnd1tm1Phin/Ccnd1tm1Phin
Tg(MMTV-Erbb2)NK1Mul/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased mammary gland tumor incidence J:105045
Ccng1tm1Sst/Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6) 		decreased hepatoma incidence J:106007
Cimap2Retro/Cimap2Retro
(involves: C57BL/6J) 		decreased lung tumor incidence J:223336
Ctnnb1tm1Mmt/Ctnnb1+
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Wap-cre)11738Mam/0
Tg(Wap-Hgf)402Mig/0
(FVB.Cg-Cxcr4tm2Yzo Ctnnb1tm1Mmt Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig) 		decreased mammary gland tumor incidence in breeding females J:206839
Dhx33em1Yazh/Dhx33+
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		decreased lung tumor incidence J:299900
Dhx33em1Yazh/Dhx33em1Yazh
Krastm4Tyj/Kras+
(involves: 129S4/SvJae) 		decreased lung tumor incidence J:299900
Egr1tm1Jmi/Egr1tm1Jmi
Tg(Defcr2-TAg)#Jig/?
(involves: 129 * C57BL/6 * FVB/N) 		decreased prostate gland tumor incidence J:67125
Eif2ak3tm1.2Drc/Eif2ak3tm1.2Drc
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-MYC,-GFP*)#Rugg/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2) 		decreased prostate gland tumor incidence J:261540
Eif4eGt(RRO036)Byg/Eif4e+
Krastm3Tyj/Kras+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N) 		decreased lung tumor incidence J:224214
Ets2tm1Rgo/Ets2tm5.1Rgo
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(S100a4-cre)1Gle/0
(involves: 129S2/SvPas * FVB/N) 		decreased mammary gland tumor incidence J:153747
Ets2tm1Rgo/Ets2tm5.1Rgo
Tg(MMTV-PyVT)634Mul/0
Tg(S100a4-cre)1Gle/0
(involves: 129S2/SvPas * FVB/N) 		decreased mammary gland tumor incidence J:153747
F2rl1tm1Bpd/F2rl1tm1Bpd
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rl1tm1Bpd Tg(MMTV-PyVT)634Mul) 		decreased mammary gland tumor incidence J:138924
Fastm1Ach/Fastm1Ach
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae) 		decreased ovarian tumor incidence J:161953
Fgfr3tm1Dor/Fgfr3tm1Dor
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-Fgf9,-EGFP)#Dor/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB) 		decreased organ/body region tumor incidence J:204282
Fgfr4tm1Cxd/Fgfr4tm1Cxd
Tg(Myl2-FGF19)1Dfre/0
(involves: 129S6/SvEvTac * FVB/N) 		decreased liver tumor incidence J:187236
Foxm1tm1Rhc/Foxm1tm1Rhc
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased liver tumor incidence J:89472
Gata6osem1Zfa/Gata6osem1Zfa
ApcMin/Apc+
(involves: C57BL/6J) 		decreased intestinal adenoma incidence J:268724
Ggta1tm1Jbl/Ggta1tm1Jbl
(involves: 129S2/SvPas) 		decreased lung tumor incidence J:90851
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi
(involves: 129 * C57BL/6 * CBA) 		decreased gland tumor incidence J:289183
Hcs7C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		decreased liver tumor incidence J:31507
Hpcr1C57BL/6J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr1C57BL/6J/Hpcr1DBA/2J
Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr1DBA/2J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr2DBA/2J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Il6sttm1Ern/Il6sttm1Ern
Tg(RP11-H2112)5Trme/0
(involves: 129S1/Sv * C57BL/6J * DBA/2J) 		decreased stomach tumor incidence J:234656
Il6sttm1Ern/Il6sttm1Ern
Tg(RP11-H2112)9Trme/0
(involves: 129S1/Sv * C57BL/6J * DBA/2J) 		decreased stomach tumor incidence J:234656
Itgb1tm1Mll/Itgb1tm1Mll
Tg(MMTV-cre)7Mul/0
Tg(MMTV-PyVT)634Mul/0
(involves: 129X1/SvJ * FVB/N) 		decreased mammary gland tumor incidence J:92547
Itih4tm1Mish/Itih4tm1Mish
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6 * NIH Black Swiss) 		decreased liver tumor incidence J:132133
Krasb/Krasb
(multiple strains) 		decreased lung tumor incidence J:17778, J:17850
Krastm3Tyj/Kras+
Mir21atm1.1Eno/Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		decreased lung tumor incidence J:164198
Krastm3Tyj/Kras+
Pik3catm1Jdo/Pik3catm1Jdo
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		decreased lung tumor incidence J:122866
Krastm3Tyj/Krastm3Tyj
Mir301tm1Yoli/Mir301tm1Yoli
(involves: 129S4/SvJae * C57BL/6J) 		decreased lung tumor incidence J:237900
decreased skin tumor incidence J:237900
Krastm4Tyj/Kras+
Pik3r1tm1Lca/Pik3r1tm1Lca
Pik3r2tm1Lca/Pik3r2tm1Lca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		decreased lung tumor incidence J:142254
Krastm4Tyj/Kras+
Rnf7Gt(XE423)Byg/Rnf7tm1.1Ysun
(involves: 129P2/OlaHsd * 129S4/SvJae) 		decreased lung tumor incidence J:207982
Krastm4Tyj/Kras+
Siva1tm1.1Att/Siva1tm1.2Att
(involves: 129S4/SvJae * C57BL/6) 		decreased lung tumor incidence J:223572
Krastm4Tyj/Kras+
Siva1tm1.2Att/Siva1+
(involves: 129S4/SvJae * C57BL/6) 		decreased lung tumor incidence J:223572
Krastm4Tyj/Kras+
Ube2cem1Gpt/Ube2cem1Gpt
(involves: 129S4/SvJae * C57BL/6J) 		decreased lung tumor incidence J:333347
MetPar4/Met+
(involves: BALB/cJ * SWR/J) 		decreased lung tumor incidence J:43176
Mir31em1Nju/Mir31em1Nju
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6J * FVB/N) 		decreased mammary gland tumor incidence J:271420
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J) 		decreased prostate gland tumor incidence J:223213
MtdhGt(XB780)Byg/Mtdh+
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul) 		decreased mammary gland tumor incidence J:214244
MtdhGt(XB780)Byg/Mtdh+
Tg(Wnt1)1Hev/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(Wnt1)1Hev) 		decreased mammary gland tumor incidence J:214244
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul) 		decreased mammary gland tumor incidence J:214244
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTVneu)202Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTVneu)202Mul) 		decreased mammary gland tumor incidence J:214244
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(Wnt1)1Hev/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(Wnt1)1Hev) 		decreased mammary gland tumor incidence J:214244
Mtdhtm1.2Dsar/Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)) 		decreased cardiovascular system tumor incidence J:216688
decreased liver tumor incidence J:216688
decreased lung tumor incidence J:216688
decreased organ/body region tumor incidence J:216688
Myctm2Fwa/Myc+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:319454
Myct1em1Choi/Myct1em1Choi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N) 		decreased mammary gland tumor incidence J:303692
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd) 		decreased liver tumor incidence J:103464
Ncoa3tm1Jxu/Ncoa3tm1Jxu
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1) 		decreased mammary gland tumor incidence J:88789
Nell1tm1Kuv/Nell1tm1Kuv
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(BGLAP-cre)1Clem/0
(involves: 129 * FVB/NJ) 		decreased osteosarcoma incidence J:326989
Nmral1Gt(S8-10A1)Sor/Nmral1Gt(S8-10A1)Sor
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Nmral1Gt(S8-10A1)Sor Tg(MMTV-PyVT)634Mul) 		decreased mammary gland tumor incidence J:282813
Par5BALB/cJ/?
(involves: BALB/cJ * SWR/J) 		decreased lung tumor incidence J:43176
Pas14A/J/?
(involves: A/J * C57BL/6J * M. spretus) 		decreased lung tumor incidence J:29218
Pas14A/J/?
(involves: A/J * C57BL/6J) 		decreased lung tumor incidence J:86399
Pas17M. spretus/?
(involves: A/J * C57BL/6J * M. spretus) 		decreased lung tumor incidence J:29218
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
Tg(MMTVneu)202Mul/0
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N) 		decreased mammary gland tumor incidence J:152332
Plbcq6FVB/NJ/?
(involves: FVB/NJ * M16i) 		decreased mammary gland tumor incidence J:136011
Pldmq1FVB/NJ/?
(involves: FVB/NJ * M16i) 		decreased mammary gland tumor incidence J:136011
Pold4em1Zzho/Pold4em1Zzho
(C57BL/6-Pold4em1Zzho) 		decreased liver tumor incidence J:331883
Prmt1tm1a(EUCOMM)Wtsi/Prmt1tm1a(EUCOMM)Wtsi
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:245660
Rb1tm3Tyj/Rb1+
Sox2tm4.1Skn/Sox2+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:318885
Rb1tm3Tyj/Rb1+
Sox2tm4.1Skn/Sox2tm4.1Skn
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:318885
Rhojtm1.2Auem/Rhojtm1.2Auem
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * CBA/JNCrlj * FVB/N) 		decreased mammary gland tumor incidence J:208154
Rr420em1Itok/Rr420em1Itok
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:319454
Rr420tm1.1Itok/Rr420tm1.1Itok
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:319454
Runx3tm1.1Itok/Runx3tm1.1Itok
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:319454
Runx3tm1Itan/Runx3+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased osteosarcoma incidence J:319454
Slc6a14tm1Gana/Slc6a14tm1Gana
Tg(MMTVneu)202Mul/0
(involves: FVB/N) 		decreased mammary gland tumor incidence J:226105
Slc25a11em1Syki/Slc25a11+
Krastm3Tyj/Kras+
(involves: 129S * C57BL/6) 		decreased lung tumor incidence J:294965
Terttm1Rdp/Terttm1Rdp
(B6.Cg-Terttm1Rdp) 		decreased liver tumor incidence J:108914
Tg(Bglap2-TAg)1Rkho/0
Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * FVB/N) 		decreased osteosarcoma incidence J:234128
Tg(CAG-Aes,-ALPP)1Lbe/0
Tg(CAG-Tle1,-ALPP)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased lung tumor incidence J:106684
Tg(CAG-SAC/EGFP)35Rang/0
(involves: C3H * C57BL/6) 		decreased liver tumor incidence J:125633
Tg(Ela-KRAS*G12D)9Eps/0
Tgfbr1tm1Bopa/Tgfbr1+
Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: 129S1/SvImJ * C57BL/6 * FVB) 		decreased gland tumor incidence J:231759
Tg(MMTV-PyVT)634Mul/0
(multiple strains) 		decreased mammary gland tumor incidence J:48854
Tgfb1i1tm1.2Cet/Tgfb1i1tm1.2Cet
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		decreased mammary gland tumor incidence J:241234
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		decreased liver tumor incidence J:143870
decreased lung tumor incidence J:143870
Zmynd8em1Lwb/Zmynd8em1Lwb
Tg(MMTV-cre)4Mam/0
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB) 		decreased mammary gland tumor incidence J:326848
Zmynd8em1Lwb/Zmynd8em1Lwb
Tg(MMTV-PyVT)634Mul/0
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6N * CBA * FVB) 		decreased mammary gland tumor incidence J:326848
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory